Krilogy Financial LLC Gsk PLC Transaction History

Krilogy Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $16,858 - $19,039	-446 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $17,728 - $19,039	446 New	446 $18,000
Q2 2018 Aug 15, 2018	SELL	$39.61 - $42.76 $17,190 - $18,557	-434 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $217 - $240	6 Added 1.4%	434 $17,000
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $36,117 - $42,821	-1,022 Reduced 70.48%	428 $15,000
Q3 2017 Nov 15, 2017	BUY	$39.44 - $41.55 $32,656 - $34,403	828 Added 133.12%	1,450 $59,000
Q2 2017 Aug 15, 2017	BUY	N/A	622	622 $27,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.